Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials

BJU Int. 2008 Nov;102(10):1366-8. doi: 10.1111/j.1464-410X.2008.08027.x. Epub 2008 Sep 3.

Authors

Akash Nanda¹, Anthony V D'Amico

Affiliation

¹ Harvard Radiation Oncology Program, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA. ananda@partners.org

PMID: 18778343
DOI: 10.1111/j.1464-410X.2008.08027.x

No abstract available

Publication types

Review

MeSH terms

Androgens / metabolism
Antineoplastic Agents, Hormonal / therapeutic use*
Combined Modality Therapy / methods
Evidence-Based Medicine
Humans
Male
Neoplasms, Hormone-Dependent / therapy*
Prostatic Neoplasms / therapy*
Radiation Dosage*
Randomized Controlled Trials as Topic
Risk Factors

Substances

Androgens
Antineoplastic Agents, Hormonal